X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (276) 276
dpp-iv (265) 265
humans (249) 249
animals (209) 209
glucagon-like peptide-1 (167) 167
dipeptidyl peptidase 4 - metabolism (143) 143
type 2 diabetes (140) 140
male (137) 137
diabetes mellitus, type 2 - drug therapy (126) 126
diabetes (123) 123
rats (115) 115
chemistry, medicinal (113) 113
biochemistry & molecular biology (97) 97
endocrinology & metabolism (93) 93
pharmacology & pharmacy (93) 93
dipeptidyl-peptidase iv inhibitors - pharmacology (92) 92
dpp-iv inhibitor (83) 83
female (82) 82
glp-1 (82) 82
mice (73) 73
dpp-iv inhibitors (70) 70
glucose (70) 70
hypoglycemic agents - therapeutic use (70) 70
sitagliptin (69) 69
peptides (68) 68
chemistry, organic (66) 66
dipeptidyl-peptidase iv inhibitors - therapeutic use (65) 65
analysis (63) 63
middle aged (62) 62
dipeptidyl-peptidase iv inhibitors - chemistry (61) 61
food science & technology (58) 58
structure-activity relationship (58) 58
dipeptidyl peptidase 4 - chemistry (56) 56
hypoglycemic agents - pharmacology (56) 56
dipeptidyl peptidase iv (54) 54
blood glucose - metabolism (52) 52
dipeptidyl-peptidase-iv (50) 50
potent (49) 49
enzymes (47) 47
glycemic control (47) 47
inhibition (47) 47
dpp iv (45) 45
sitagliptin phosphate (45) 45
proteins (44) 44
aged (42) 42
discovery (42) 42
hypoglycemic agents (42) 42
dipeptidyl peptidase-iv (41) 41
vildagliptin (41) 41
dextrose (40) 40
adult (39) 39
dpp‐iv inhibitor (39) 39
drug design (39) 39
insulin (38) 38
bioactive peptides (36) 36
dipeptidyl-peptidase iv inhibitors (36) 36
identification (35) 35
inhibitors (35) 35
type-2 diabetes-mellitus (35) 35
diabetes mellitus, type 2 - blood (34) 34
dose-response relationship, drug (34) 34
expression (34) 34
cd26 (33) 33
diabetes mellitus (33) 33
diabetes therapy (33) 33
hydrolysis (33) 33
proteases (33) 33
double-blind method (32) 32
glucose tolerance test (32) 32
protein (32) 32
adamantane - analogs & derivatives (31) 31
dipeptidyl-peptidase iv inhibitors - chemical synthesis (31) 31
in-vitro (31) 31
beta-cell function (30) 30
diabetes mellitus, type 2 - metabolism (30) 30
dipeptidyl-peptidase iv inhibitors - administration & dosage (30) 30
glucagon (30) 30
hypoglycemic agents - chemistry (30) 30
molecular structure (30) 30
protease inhibitors - pharmacology (30) 30
rats, wistar (30) 30
treatment outcome (30) 30
blood glucose - drug effects (29) 29
improved glucose-tolerance (29) 29
incretins (29) 29
binding sites (28) 28
double-blind (28) 28
inhibitory concentration 50 (28) 28
peptidase (28) 28
secretion (28) 28
highly potent (27) 27
incretin (27) 27
administration, oral (26) 26
crystal-structure (26) 26
glucagon-like peptide 1 (26) 26
metformin (26) 26
physiological aspects (26) 26
care and treatment (25) 25
degradation (25) 25
dipeptidyl peptidase 4 (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 09/2019, Volume 859, p. 172521
Dipeptidyl peptidase-4 (DPP-4) inhibitors prevent the degradation of glucagon-like peptide-1 (GLP-1) and improve glycemic control. The GLP-1 insulinotropic... 
Dipeptidyl peptidase-4 inhibitor | Glucagon-like peptide-1 | Hepatic portal | Intestine | Dipeptidyl peptidase-4 | LOCALIZATION | METFORMIN | PHYSIOLOGY | DPP-IV | GLP-1 | INSULIN-SECRETION | TISSUE | MECHANISMS | ANAGLIPTIN | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Journal Article
Journal of Applied Pharmaceutical Science, 01/2019, Volume 9, Issue 1, pp. 28 - 32
Journal Article
Synthetic Communications, ISSN 0039-7911, 11/2018, Volume 48, Issue 22, pp. 2877 - 2887
Herein, we have designed various benzisoxazole acetamide derivatives with and without glycine spacer as DPP-IV inhibitors. Compounds 9a-d and 11a-e were... 
DPP-IV inhibition | 1,2-benzisoxazole derivatives | anticancer activity | antidiabetic activity | CELLS | DESIGN | DIPEPTIDYL-PEPTIDASE-IV | 2-benzisoxazole derivatives | CHEMISTRY, ORGANIC | AGONISTS | BENZOXAZOLE | POTENT | CD26 | EXPRESSION
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 11/2008, Volume 69, Issue 5, pp. 737 - 744
Journal Article